Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Phase 4 Study of Sivelestat Sodium in ARDS
ChiCTR2100046772Phase 4Recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute respiratory distress syndrome (ARDS) comparing Test group (sivelestat sodium) with Control group (normal saline placebo) (2 arms). Primary endpoints: Oxygenation index (PaO2/FiO2) and Mechanical ventilation time. Started May 2021; status: recruiting.
02
Drugs
sivelestat
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on ChiCTR2100046772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046772.